Fundraising Fox
/Companies
Sign in

MinervaX

84 employees on LinkedIn · 13 known investors

Find your way into MinervaX

Sign up to find every way you can get introduced to MinervaX

  • Your email: who you already know at MinervaX, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MinervaX team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease. Its work spans vaccine discovery through late-stage clinical development and regulatory approval.

BiotechHealthtech

Founders & leadership

P
Per
B
BengtCSO

Investors · 13

Industrifonden✓ confirmed by MinervaXStockholm · $960K – $4.8M

How we know: Industrifonden's portfolio page · the company's own site · funding news · minervax.com · Not right? Tell us

OrbiMed✓ confirmed by MinervaXNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the company's own site · funding news · minervax.com · the VCSheet dataset · Not right? Tell us

Pureos Bioventures✓ confirmed by MinervaXPfäffikon

How we know: Pureos Bioventures's portfolio page · the company's own site · a partner's Signal profile · Not right? Tell us

Sanofi Ventures✓ confirmed by MinervaXCambridge · $5M

How we know: Sanofi Ventures's portfolio page · the company's own site · a partner's Signal profile · funding news · minervax.com · the VCSheet dataset · Not right? Tell us

Sunstone Capital✓ confirmed by MinervaXFrederiksberg

How we know: Sunstone Capital's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

EQT Life Sciences✓ confirmed by MinervaXLuxembourg · $11M – $66M

How we know: the company's own site · a partner's Signal profile · funding news · minervax.com · Not right? Tell us

Novo Holdings✓ confirmed by MinervaXCopenhagen · $1.1M – $54M

How we know: the company's own site · minervax.com · Not right? Tell us

LU Innovationlisted by LU InnovationLund

How we know: LU Innovation's portfolio page · Not right? Tell us

Also in the syndicate · 4

LF InvestPureos VenturesSunstone LifeScience VenturesTrill Impact Ventures

Founder mafia

2 people who came through MinervaX went on to found or lead other companies.

Veronica Gambillara FonckChairperson of the BoardFounded LimmaTech Biologics +1Sten VerlandNon Executive DirectorFounded Taconic Biosciences

In the news

Our Investors | MinervaXminervax.com · Apr 2024Press Releases | MinervaXminervax.com · Apr 2024MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus | MinervaXminervax.com · Oct 2023MinervaX announces completion of 47.4 mEUR financing | MinervaXminervax.com · Dec 2020

Frequently asked questions

What does MinervaX do?
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease. Its work spans vaccine discovery through late-stage clinical development and regulatory approval.
Who are MinervaX's investors?
MinervaX's investors include Adjuvant Capital, Industrifonden, OrbiMed, Pureos Bioventures, Sanofi Ventures, Sunstone Capital, EQT Life Sciences, Novo Holdings and 1 more.